Evolution of disease activity and biomarkers on and off rapamycin in 28 patients with autoimmune lymphoproliferative syndrome
Klemann C, Esquivel M, Magerus-Chatinet A, Lorenz M, Fuchs I, Neveux N, Castelle M, Rohr J, Bettoni da Cunha C, Ebinger M, Kobbe R, Kremens B, Kollert F, Gambineri E, Lehmberg K, Seidel M, Siepermann K, Voelker T, Schuster V, Goldacker S, Schwarz K, Speckmann C, Picard C, Fischer A, Rieux-Laucat F, Ehl S, Rensing-Ehl A, Neven B
HAEMATOLOGICA. 2017;102(2):e52-e56.

The Extended Clinical Phenotype of 26 Patients with Chronic Mucocutaneous Candidiasis due to Gain-of-Function Mutations in STAT1
Depner M, Fuchs S, Raabe J, Frede N, Glocker C, Doffinger R, Gkrania-Klotsas E, Kumararatne D, Atkinson T, Schroeder H, Niehues T, Dückers G, Stray-Pedersen A, Baumann U, Schmidt R, Franco J, Orrego J, Ben-Shoshan M, McCusker C, Jacob C, Carneiro-Sampaio M, Devlin L, Edgar J, Henderson P, Russell R, Skytte A, Seneviratne S, Wanders J, Stauss H, Meyts I, Moens L, Jesenak M, Kobbe R, Borte S, Borte M, Wright D, Hagin D, Torgerson T, Grimbacher B
J CLIN IMMUNOL. 2016;36(1):73-84.

Common variable immunodeficiency, impaired neurological development and reduced numbers of T regulatory cells in a 10-year-old boy with a STAT1 gain-of-function mutation
Kobbe R, Kolster M, Fuchs S, Schulze-Sturm U, Jenderny J, Kochhan L, Staab J, Tolosa E, Grimbacher B, Meyer T
GENE. 2016;586(2):234-8.

Dolutegravir in breast milk and maternal and infant plasma during breastfeeding
Kobbe R, Schalkwijk S, Dunay G, Eberhard J, Schulze-Sturm U, Hollwitz B, Degen O, Teulen M, Colbers A, Burger D
AIDS. 2016;30(17):2731-2733.

Empfehlungen zur infektiologischen Versorgung von Flüchtlingen im Kindes- und Jugendalter in Deutschland: Stellungnahme der Deutschen Gesellschaft für Pädiatrische Infektiologie, der Gesellschaft für Tropenpädiatrie und Internationale Kindergesundheit und des Berufsverbandes der Kinder- und Jugendärzte
Pfeil J, Kobbe R, Trapp S, Kitz C, Hufnagel M
INTERNIST. 2016;57(5):416-33.

Hyperactive mTOR pathway promotes lymphoproliferation and abnormal differentiation in autoimmune lymphoproliferative syndrome
Rensing-Ehl A, Allgäuer A, Schreiner E, Lorenz M, Rohr J, Klemann C, Fuchs I, Schuster V, von Bueren A, Naumann-Bartsch N, Gambineri E, Siepermann K, Kobbe R, Nathrath M, Arkwright P, Miano M, Stachel K, Metzler M, Schwarz K, Kremer A, Speckmann C, Ehl S, Mackensen A
BLOOD. 2016;128(2):227-38.

Risk of Rotavirus Vaccination for Children with SCID
Klinkenberg D, Blohm M, Hoehne M, Mas Marques A, Malecki M, Schildgen V, Schneppenheim R, Müller I, Schildgen O, Kobbe R
PEDIATR INFECT DIS J. 2015;34(1):114-5.

Geographically weighted regression of land cover determinants of Plasmodium falciparum transmission in the Ashanti Region of Ghana
Ehlkes L, Krefis A, Kreuels B, Krumkamp R, Adjei O, Ayim-Akonor M, Kobbe R, Hahn A, Vinnemeier C, Loag W, Schickhoff U, May J
INT J HEALTH GEOGR. 2014;13:35.

Hypereosinophiles Syndrom (HES) nach Lebertransplantation
Aulbert W, Breuer C, Oh J, Briem-Richter A, Kobbe R, Ganschow R
2013.

Ungewöhnlicher Haut- und Skelettbefund – Infantile Myofibromatose
Warlitz C, Kobbe R, Helmke K, Höger P, Singer D
Z GEBURTSH NEONATOL . 2013;217(3):112-3.

Follow-up survey of children who received sulfadoxine-pyrimethamine for intermittent preventive antimalarial treatment in infants
Kobbe R, Hogan B, Adjei S, Klein P, Kreuels B, Loag W, Adjei O, May J
J INFECT DIS. 2011;203(4):556-60.

IL3 variant on chromosomal region 5q31-33 and protection from recurrent malaria attacks
Meyer C, Calixto Fernandes M, Intemann C, Kreuels B, Kobbe R, Kreuzberg C, Ayim M, Ruether A, Loag W, Ehmen C, Adjei S, Adjei O, Horstmann R, May J
HUM MOL GENET. 2011;20(6):1173-81.

Open-source genomic analysis of Shiga-toxin-producing E. coli O104:H4.
Rohde H, Qin J, Cui Y, Li D, Loman N, Hentschke M, Chen W, Pu F, Peng Y, Li J, Xi F, Li S, Li Y, Zhang Z, Yang X, Zhao M, Wang P, Guan Y, Cen Z, Zhao X, Christner M, Kobbe R, Loos S, Oh J, Yang L, Danchin A, Gao G, Song Y, Li Y, Yang H, Wang J, Xu J, Pallen M, Wang J, Aepfelbacher M, Yang R, Consortium E
NEW ENGL J MED. 2011;365(8):718-724.

Multiplicity of Plasmodium falciparum infection following intermittent preventive treatment in infants
Buchholz U, Kobbe R, Danquah I, Zanger P, Reither K, Abruquah H, Grobusch M, Ziniel P, May J, Mockenhaupt F
MALARIA J. 2010;9:244.

Novel human parvovirus 4 genotype 3 in infants, Ghana
Panning M, Kobbe R, Vollbach S, Drexler J, Adjei S, Adjei O, Drosten C, May J, Eis-Hubinger A
EMERG INFECT DIS. 2010;16(7):1143-6.

Efficacy and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in African infants
Aponte J, Schellenberg D, Egan A, Breckenridge A, Carneiro I, Critchley J, Danquah I, Dodoo A, Kobbe R, Lell B, May J, Premji Z, Sanz S, Sevene E, Soulaymani-Becheikh R, Winstanley P, Adjei S, Anemana S, Chandramohan D, Issifou S, Mockenhaupt F, Owusu-Agyei S, Greenwood B, Grobusch M, Kremsner P, Macete E, Mshinda H, Newman R, Slutsker L, Tanner M, Alonso P, Menendez C
LANCET. 2009;374(9700):1533-42.

Q fever in young children, Ghana
Kobbe R, Kramme S, Kreuels B, Adjei S, Kreuzberg C, Panning M, Adjei O, Fleischer B, May J
EMERG INFECT DIS. 2008;14(2):344-6.

Simvastatin treatment shows no effect on the incidence of cerebral malaria or parasitemia during experimental malaria
Kobbe R, Schreiber N, May J, Jacobs T
ANTIMICROB AGENTS CH. 2008;52(4):1583-4.

Spatial variation of malaria incidence in young children from a geographically homogeneous area with high endemicity
Kreuels B, Kobbe R, Adjei S, Kreuzberg C, von Reden C, Bäter K, Klug S, Busch W, Adjei O, May J
J INFECT DIS. 2008;197(1):85-93.

Therapeutic and prophylactic effect of intermittent preventive anti-malarial treatment in infants (IPTi) from Ghana and Gabon
May J, Adjei S, Busch W, Gabor J, Issifou S, Kobbe R, Kreuels B, Lell B, Schwarz N, Adjei O, Kremsner P, Grobusch M
MALARIA J. 2008;7:198.

Malaria incidence and efficacy of intermittent preventive treatment in infants (IPTi)
Kobbe R, Adjei S, Kreuzberg C, Kreuels B, Thompson B, Thompson P, Marks F, Busch W, Tosun M, Schreiber N, Opoku E, Adjei O, Meyer C, May J
MALARIA J. 2007;6:163.

Travel-associated Coxiella burnetii infections
Kobbe R, Kramme S, Gocht A, Werner M, Lippert U, May J, Burchard G
TRAVEL MED INFECT DI. 2007;5(6):374-9.

A randomized controlled trial of extended intermittent preventive antimalarial treatment in infants
Kobbe R, Kreuzberg C, Adjei S, Thompson B, Langefeld I, Thompson P, Abruquah H, Kreuels B, Ayim M, Busch W, Marks F, Amoah K, Opoku E, Meyer C, Adjei O, May J
CLIN INFECT DIS. 2007;45(1):16-25.

Chloroquine-resistant malaria in Malawi
Kobbe R, Meyer C, May J
NEW ENGL J MED. 2007;356(8):868; author reply 869.

Immune responses after single-dose sulphadoxine-pyrimethamine indicate underestimation of protective efficacy of intermittent preventive treatment in infants
Schreiber N, Kobbe R, Adjei S, Adjei O, Klinkert M, May J
TROP MED INT HEALTH. 2007;12(10):1157-63.

Seasonal variation and high multiplicity of first Plasmodium falciparum infections in children from a holoendemic area in Ghana, West Africa
Kobbe R, Neuhoff R, Marks F, Adjei S, Langefeld I, von Reden C, Adjei O, Meyer C, May J
TROP MED INT HEALTH. 2006;11(5):613-9.

Editorial
Kobbe R, Marks F, May J, Meyer C
TROP MED INT HEALTH. 2005;10(4):293-4.

Parasitological rebound effect and emergence of pyrimethamine resistance in Plasmodium falciparum after single-dose sulfadoxine-pyrimethamine
Marks F, von Kalckreuth V, Kobbe R, Adjei S, Adjei O, Horstmann R, Meyer C, May J
J INFECT DIS. 2005;192(11):1962-5.

Letzte Aktualisierung aus dem FIS: 17.07.2017 - 00:01 Uhr